- Home
- KRYS vs CLSK Comparison
KRYS vs CLSK Comparison
Compare KRYS & CLSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- CLSK
- Stock Information
- Founded
- KRYS 2015
- CLSK 1987
- Country
- KRYS United States
- CLSK United States
- Employees
- KRYS N/A
- CLSK N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- CLSK Finance: Consumer Services
- Sector
- KRYS Health Care
- CLSK Finance
- Exchange
- KRYS Nasdaq
- CLSK Nasdaq
- Market Cap
- KRYS 6.3B
- CLSK 5.7B
- IPO Year
- KRYS 2017
- CLSK N/A
- Fundamental
- Price
- KRYS $221.08
- CLSK $13.44
- Analyst Decision
- KRYS Strong Buy
- CLSK Strong Buy
- Analyst Count
- KRYS 9
- CLSK 11
- Target Price
- KRYS $214.22
- CLSK $23.83
- AVG Volume (30 Days)
- KRYS 335.7K
- CLSK 33.5M
- Earning Date
- KRYS 11-03-2025
- CLSK 11-25-2025
- Dividend Yield
- KRYS N/A
- CLSK N/A
- EPS Growth
- KRYS 275.72
- CLSK N/A
- EPS
- KRYS 6.66
- CLSK 1.12
- Revenue
- KRYS $373,164,000.00
- CLSK $766,314,000.00
- Revenue This Year
- KRYS $34.33
- CLSK $45.24
- Revenue Next Year
- KRYS $48.04
- CLSK $11.50
- P/E Ratio
- KRYS $32.83
- CLSK $12.01
- Revenue Growth
- KRYS 54.51
- CLSK 102.21
- 52 Week Low
- KRYS $122.80
- CLSK $6.45
- 52 Week High
- KRYS $221.84
- CLSK $23.61
- Technical
- Relative Strength Index (RSI)
- KRYS 76.21
- CLSK 48.38
- Support Level
- KRYS $203.17
- CLSK $9.06
- Resistance Level
- KRYS $212.97
- CLSK $11.18
- Average True Range (ATR)
- KRYS 7.05
- CLSK 1.20
- MACD
- KRYS 0.96
- CLSK -0.02
- Stochastic Oscillator
- KRYS 98.60
- CLSK 58.32
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About CLSK CleanSpark Inc.
Cleanspark Inc is a bitcoin mining company. Through CleanSpark, Inc., and the Company's wholly owned subsidiaries, the company mines bitcoin. The company entered the bitcoin mining industry through its acquisition of ATL. Bitcoin mining is the sole reportable segment of the company.